Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Marcon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Tumori|December 24, 2013
Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centersNicla La Verde, Elena Collovà, Sara Lonardi, et al.
Cancers|April 13, 2023
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN StudyMichele Del Vecchio, Vanna Chiarion Sileni, Pietro Quaglino, et al.
Tumori|October 10, 2014
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysisElena Collovà, Antonella Ferzi, Giuseppa Scandurra, et al.
Tumori|July 14, 2015
Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncologyGaetano Aurilio, Stefania Gori, Franco Nolè, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Tumori|December 24, 2013
Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centersNicla La Verde, Elena Collovà, Sara Lonardi, et al.
Cancers|April 13, 2023
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN StudyMichele Del Vecchio, Vanna Chiarion Sileni, Pietro Quaglino, et al.
Tumori|October 10, 2014
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysisElena Collovà, Antonella Ferzi, Giuseppa Scandurra, et al.
Tumori|July 14, 2015
Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncologyGaetano Aurilio, Stefania Gori, Franco Nolè, et al.
Pageof 2